MCRB
Seres Therapeutics Inc
3.60$
-4.5%
vs. previous close
Closing price · As of: Sep 24, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -79.4% | -100.0% | – | – | – | -100.0% | – | – | +24.8% | -18.3% | +105.6% | – | |
| – | -14.6% | +381.0% | -92.7% | -1.1% | +265.2% | -31.2% | -70.0% | +1,160.8% | -203.4% | – | -100.0% | – | |
| – | – | -30,559.4% | – | – | – | – | – | – | – | -103.0% | – | – | |
| – | +6.7% | -27.4% | -18.9% | +4.1% | -22.0% | -7.9% | +9.5% | -2.5% | -7.4% | +12.9% | -30.7% | – | |
| – | -11.3% | -13.3% | -12.6% | -2.7% | -2.0% | -4.6% | -13.8% | -7.6% | -20.4% | +7.0% | -12.5% | – | |
| – | -0.6% | -62.3% | +93.2% | -3.8% | -14.6% | +0.0% | +0.5% | -60.2% | +254.8% | -39.1% | +7.4% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +0.4% | +15.7% | -26.1% | -100.0% | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | -160.8% | – | -286.9% | – | – | – | |
| – | -252.4% | – | -100.0% | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | -117.6% | – | -160.8% | – | -286.9% | – | – | – | |
| – | – | – | – | – | – | – | -155.7% | – | -242.5% | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.